Talk:Darolutamide

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by MaynardClark (talk | contribs) at 04:30, 16 February 2024. The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

INTREPId Study[edit]

Note the multicentered Darolutamide clinical trials.[1] MaynardClark (talk) 04:30, 16 February 2024 (UTC)[reply]

References

Long-term outcomes after treatment[edit]

Doesn't this article NEED some knowledge about long-term outcomes after treatment in research subjects (and also in clinical experience after years of treating patients). Is there no other way to discuss these issues without sounding like the pharmaceutical marketing literature? MaynardClark (talk) 04:30, 16 February 2024 (UTC)[reply]